日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients With Eosinophilic Granulomatosis With Polyangiitis

贝那利珠单抗和美泊利珠单抗对嗜酸性肉芽肿性血管炎患者口服糖皮质激素使用的影响

Nair, Parameswaran K; Hellmich, Bernhard; Bourdin, Arnaud; Jayne, David R W; Roufosse, Florence; Khalidi, Nader; Börjesson Sjö, Lena; Fan, Ying; McCrae, Christopher; Necander, Sofia; Rodríguez-Suárez, Eva; Shavit, Anat; Walton, Claire; Merkel, Peter A; Wechsler, Michael E

Benralizumab reduces sputum ANCA in patients with eosinophilic granulomatosis with polyangiitis

贝那利珠单抗可降低嗜酸性肉芽肿性血管炎患者痰液中的ANCA水平

Mukherjee, Manali; Tan, Nadia Suray; Huang, Chynna; Kim, Brian; Radford, Katherine; Ju, Xiaotian; Venegas Garrido, Carmen; Kjarsgaard, Melanie; Rodríguez-Suárez, Eva; Wechsler, Michael E; Walker, Brandie; Börjesson Sjö, Lena; Necander, Sofia; Ashkar, Ali; Weidner, Julie; Sehmi, Roma; McCrae, Christopher; Khalidi, Nader; Nair, Parameswaran

Discontinuation of Oral Glucocorticoids and Achievement of Remission in Patients With Eosinophilic Granulomatosis With Polyangiitis Treated With Benralizumab or Mepolizumab

停用口服糖皮质激素及接受贝那利珠单抗或美泊利珠单抗治疗的嗜酸性肉芽肿性血管炎患者达到缓解

Wechsler, Michael E; Agmon-Levin, Nancy; Jayne, David R W; Pagnoux, Christian; Specks, Ulrich; Börjesson Sjö, Lena; Necander, Sofia; Shavit, Anat; Walton, Claire; Merkel, Peter A

The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD

新型支气管扩张剂纳伐芬特罗:一项针对慢性阻塞性肺疾病的 2a 期多中心随机双盲安慰剂对照交叉试验

Singh, Dave; Beier, Jutta; Astbury, Carol; Belvisi, Maria G; Da Silva, Carla A; Jauhiainen, Alexandra; Jimenez, Eulalia; Lei, Alejhandra; Necander, Sofia; Smith, Jaclyn A; Wählby Hamrén, Ulrika; Xin, Wenjing; Psallidas, Ioannis

Physical activity end-points in trials of chronic respiratory diseases: summary of evidence

慢性呼吸系统疾病试验中体力活动终点:证据总结

Rist, Cassie; Karlsson, Niklas; Necander, Sofia; Da Silva, Carla A